The effect of Chinese herbal medicine on digestive system and liver functions should not be neglected in COVID‐19: An updated systematic review and meta‐analysis

Shihua Shi,Fei Wang,Jiang Li,Yulong Li,Weihao Li,Xiaoping Wu,Shuo Kou,Yongcan Wu,Xiaomin Wang,Caixia Pei,Demei Huang,Heng Qiu,Peili Wang,Zhenxing Wang
DOI: https://doi.org/10.1002/iub.2467
IF: 4.7087
2021-04-02
IUBMB Life
Abstract:<p>Gastrointestinal symptoms and liver injury are common in patients with coronavirus disease 2019 (COVID‐19). However, profiles of different pharmaceutical interventions used are relatively underexplored. Chinese herbal medicine (CHM) has been increasingly used for patients with COVID‐19, but the efficacy of CHM used in COVID‐19 on gastrointestinal symptoms and liver functions has not been well studied with definitive results based on the updated studies. The present study aimed at testing the efficacy of CHM on digestive symptoms and liver function (primary outcomes), the aggravation of COVID‐19 and the time to viral assay conversion (secondary outcomes), among patients with COVID‐19, compared with standard pharmacotherapy. Literature search was undertaken in 11 electronic databases from December 1, 2019 up to November 8, 2020. Appraisal of the evidence was conducted with Cochrane risk of bias tool or Newcastle Ottawa Scale. A random effects model or subgroup analysis was conducted when significant heterogeneity was identified in the meta‐analysis. The certainty of the evidence was assessed with the grading of recommendations assessment, development and evaluation (GRADE) approach. Forty‐eight included trials involving 4,704 participants were included. Meta‐analyses favored CHM plus standard pharmacotherapy for COVID‐19 on reducing the aggravation of COVID‐19 and the time to viral assay conversion compared with standard pharmacotherapy. However, the present CHM as a complementary therapy for treating COVID‐19 may not be beneficial for improving most gastrointestinal symptoms and liver function based on the current evidence. More well‐conducted trials are warranted to confirm the potential efficacy of CHM furtherly.</p>
cell biology,biochemistry & molecular biology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to evaluate the impact of the application of Chinese herbal medicine (CHM) in patients with COVID - 19 on digestive system symptoms and liver function. Specifically, the study aims to test the effectiveness of CHM on digestive symptoms and liver function (primary outcomes), as well as its impact on the exacerbation of COVID - 19 and the time for virus test to turn negative (secondary outcomes), compared with standard drug treatment. Through the methods of systematic review and meta - analysis, the study synthesized relevant literatures in 11 electronic databases as of November 8, 2020, to evaluate the potential efficacy of CHM as an adjuvant therapy in improving the digestive system symptoms and liver function of COVID - 19 patients. ### Research Background - **Problem Raised**: Gastrointestinal symptoms and liver injury problems commonly seen in COVID - 19 patients need attention, but currently there is relatively little data on different drug interventions. The use of Chinese herbal medicine in the treatment of COVID - 19 is increasing, but its specific efficacy on digestive system symptoms and liver function has not been fully studied. - **Research Purpose**: Through systematic review and meta - analysis, evaluate the impact of the application of Chinese herbal medicine in COVID - 19 patients on digestive system symptoms and liver function, as well as its impact on the exacerbation of the disease and the time for virus test to turn negative. ### Main Research Contents - **Primary Outcomes**: - Digestive system symptoms: including nausea remission rate, vomiting remission rate, anorexia remission rate and diarrhea remission rate. - Liver function: including the improvement rate of alanine aminotransferase (ALT) and aspartate aminotransferase (AST). - **Secondary Outcomes**: - COVID - 19 exacerbation rate. - Time for virus test to turn negative. ### Methods - **Literature Search**: Conduct a systematic search in 11 electronic databases, with the time range from December 1, 2019 to November 8, 2020. - **Inclusion Criteria**: Include randomized controlled trials (RCTs) and observational studies with control groups. - **Exclusion Criteria**: Re - published articles, review articles, case series without control groups, opinion articles, comment articles, in - vitro experimental studies, animal studies, expert opinions, etc. - **Data Extraction and Analysis**: Use the Cochrane risk - of - bias tool or the Newcastle Ottawa Scale to assess the quality of evidence, and use a random - effects model or subgroup analysis to deal with heterogeneity. ### Results - **Digestive System Symptoms**: - **Nausea Remission**: Six studies showed that CHM had no significant impact on the nausea remission rate (RR 1.04; 95% CI 0.83 - 1.30). - **Vomiting Remission**: Four studies showed that CHM had no significant impact on the vomiting remission rate (RR 1; 95% CI 0.77 - 1.29). - **Anorexia Remission**: Six studies showed that CHM combined with standard drug treatment was superior to using standard drug treatment alone in terms of anorexia remission rate (RR 2.09; 95% CI 1.04 - 4.19). - **Diarrhea Remission**: 12 studies showed that CHM had no significant impact on the diarrhea remission rate (RR 1.04; 95% CI 0.92 - 1.16). - **Liver Function**: - **ALT**: Four studies showed that CHM had no significant impact on the effective rate of ALT returning to normal (RR 1.23; 95% CI 0.91 - 1.65). - **AST**: Four studies showed that CHM had no significant impact on the effective rate of AST returning to normal (RR 1.22; 95% CI 0.92 - 1.61). - **COVID - 19 Exacerbation**: 28 studies showed that CHM combined with standard drug treatment significantly reduced the risk of COVID - 19 exacerbation (RR 0.43; 95% CI 0.34 - 0.55). - **Time for Virus Test to Turn Negative**: 19 studies showed that CHM combined with standard drug treatment significantly shortened the time for virus test to turn negative. ### Conclusions - **Main Conclusions**: CHM combined with standard drug treatment in reducing COVID - 19 exacerbation and shortening the time for virus test to turn negative...